In this study, we demonstrate an increase in ATP and nuclear Nrf2, suggesting that treatment with a low concentration of PEP-1-PGK1 facilitates anti-inflammatory and antioxidant responses in the hippocampus after ischemia. The gene discussed is PGK1; the disease is ischemia.